Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema
EXN407 is the first topical SRPK1 inhibitor to demonstrate both safety and signals of biological response as monotherapy for these indications Data generated fully... Read more.
Rotterdam Hosts European Startup Founders and Investors at Upstream to Drive Innovation for a Future Proof Economy
Upstream 2024 connects more than 2000 founders, investors and other organizations from the international startup ecosystem that are driving the transition to a digital,... Read more.
E3 Lithium Welcomes Former Alberta Energy Minister, Hon. Sonya Savage, to its Board of Directors
Highlights: The Hon. Sonya Savage, previous Minister of Energy, Minister of Justice and Solicitor General and Minister of Environment and Protected Areas for the... Read more.
Epsilogen and Lonza Announce Successful Large-Scale GMP Manufacturing of MOv18, an IgE Antibody Targeting Ovarian Cancer
First time GMP manufacturing of a therapeutic IgE antibody has been achieved at scale GMP material to be used in Phase Ib study in platinum-resistant ovarian cancer... Read more.
Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
New data shows long-term use of an AID system powered by Dexcom CGM can safely maintain improvements in glycaemic outcomes for up to two years1. Real-world evidence... Read more.
Deel Is Acquiring Payroll Company PaySpace
News comes as Deel hits $500M+ in annual recurring revenue within five years SAN FRANCISCO–(BUSINESS WIRE)–Global payroll and HR company Deel announced... Read more.
Syngenta to Reduce Carbon Impact of Ocean Shipping with Maersk’s ECO Delivery
Syngenta finalizes agreement with Maersk for ocean transport using biofuel for a Europe-US shipping route BASEL, Switzerland–(BUSINESS WIRE)–Syngenta... Read more.
Manhattan Unveils First Unified Commerce Benchmark for Specialty Retail in Europe
LONDON–(BUSINESS WIRE)–Manhattan Associates Inc. (NASDAQ: MANH) today announced the findings of the industry’s first real-world analysis of Unified... Read more.
VIAVI Solutions Agrees to Acquire Spirent Communications to Create a Leading Provider of Test, Assurance and Security Solutions for Research and Development Labs, Service Providers, Data Centers and Mission-Critical Infrastructure
Highly complementary and synergistic product portfolios to enable delivery of high-performance, integrated solutions for networking and mission-critical applications,... Read more.
bit.bio Announces First Project Within Multi-Year Collaboration Agreement with The Michael J. Fox Foundation (MJFF) to Generate Human Cell Products for Research and Drug Discovery in Parkinson’s disease
First project will prioritise the discovery and development of a key human cell type for Parkinson’s disease (PD) research and drug discovery. Collaboration... Read more.